Pleasanton, CA, United States of America

Sedide Ozturk

This inventor holds 10 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Roche Sequencing Solutions, Inc., Ventana Medical Systems, Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sedide Ozturk. Retrieved from https://idiyas.com/inventor/sedide-ozturk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 8)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 4.1

ph-index = 1

Company Filing History:

10 out of 299

Roche Sequencing Solutions, Inc.

patents

1 out of 548

Ventana Medical Systems, Inc.

patents

where one patent can have more than one assignee

Years Active: 2021-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435355 - Whole transcriptome analysis in single cells (2025-10-07),

2. 12378596 - Whole transcriptome analysis in single cells (2025-08-05),

3. 12297491 - Primer extension target enrichment and improvements thereto including simultaneous enrichment of DNA and RNA (2025-05-13),

4. 12043919 - Immune profiling by primer extension target enrichment (2024-07-23),

5. 11773511 - Immune profiling by primer extension target enrichment (2023-10-03),

6. 11725307 - Immuno-PETE (2023-08-15),

7. 11603565 - System for identification of antigens recognized by T cell receptors expressed on tumor infiltrating lymphocytes (2023-03-14),

8. 11499180 - Primer extension target enrichment and improvements thereto including simultaneous enrichment of DNA and RNA (2022-11-15),

9. 11306356 - Immuno-PETE (2022-04-19),

10. 11098360 - Immuno-PETE (2021-08-24),

Title: Inventor Spotlight: Sedide Ozturk

Introduction

Sedide Ozturk is a prominent inventor located in Pleasanton, California. With a remarkable portfolio of seven patents, he has made significant contributions to the field of immune profiling through innovative methodologies.

Latest Patents

Among Sedide Ozturk's latest patents is a method for "Immune profiling by primer extension target enrichment." This invention includes methods and compositions for primer extension target enrichment of immune receptor sequences, specifically B-cell receptors (BCR) and T-cell receptors (TCR). The advancements brought by this patent are crucial for understanding immune responses.

Career Highlights

Throughout his career, Sedide has worked with notable companies like Roche Sequencing Solutions, Inc. and Ventana Medical Systems, Inc. His work at these organizations has been pivotal in advancing the technologies associated with genetic sequencing and immune profiling.

Collaborations

Sedide Ozturk has collaborated with esteemed professionals in his field, including Jan Berka and Seoyoung Kim. Their combined expertise has propelled innovative solutions in the medical and biotechnology sectors, particularly in enhancing immune receptor sequencing techniques.

Conclusion

Sedide Ozturk stands out as a significant figure in the realm of biotechnology and immunology. His innovative patents and collaborations with industry leaders illustrate his commitment to advancing scientific knowledge and technology. As he continues to push the boundaries of research, his contributions will undoubtedly leave a lasting impact on the field.

Profile summary based on public USPTO records.